Exclusion Criteria:~* Patients with dementia other than AD.~ 1. Patient whose imaging test shows circumscribed
cerebral lesion or multiple infarcts which is suspected to be the responsible cause of dementia (mixed-type
dementia)~ 2. Patients with other types of dementia~* Patients with a current DSM-IV diagnosis of major
depressive disorder or any current serious psychiatric diagnosis othe than AD.~* Patients without a reliable
caregiver.~* Patients who are expected to enter a nursing home facility within 6 months after starting study
treatment (excluding a transient entry).~* Patients with active or clinically significant conditions affecting
absorption, distribution or metabolism of study drugs (e.g., inflammatory bowel disease, gastric or duodenal
ulcers, or severe lactose intolerance).~* Patients with a known hypersensitivity to a component of donepezil
hydrochloride preparation or piperidine derivatives.~* Patients complicated with a severe gastrointestinal,
hepatic, renal, endocrine, or cardiovascular system disease (e.g., sick sinus syndrome, intraarterial and
supraventricular conduction disorder, etc.).~* Patients with a history of severe bronchial asthma or
obstructive pulmonary disease.~* Patients with a severe extrapyramidal disease (Parkinson's disease,
Parkinson's syndrome, etc.).~* Patients with diabetes mellitus with uncontrolled blood glucose levels (HbAlc of
â‰§10%).~* Hypertension patients with uncontrolled blood pressure (diastolic blood pressure of â‰§95 mmHg).~*
Patients with uncontrolled thyroid dysfunction.~* Patients with a history of seizure or convulsion within the
previous 3 months (obtaining informed consent).~* Patients with a known or suspected history of alcohoism or
drug dependence within the recent 10 years.~* Patients with malignant tumors.~* Women of pregnant, possibly
pregnant, or lactating.~* Patients who have participated in another clinical study within the recent 3 months
(before giving consent).~* Any other patients who are judged to be ineligible for study entry by the
investigator or subinvestigator.
